Cardinal Health’s (CAH) Hold Rating Reiterated at Robert W. Baird

Robert W. Baird reiterated their hold rating on shares of Cardinal Health (NYSE:CAH) in a report released on Wednesday. They currently have a $80.00 price objective on the stock.

A number of other brokerages have also recently issued reports on CAH. Royal Bank of Canada assumed coverage on Cardinal Health in a research note on Tuesday, September 19th. They set a sector perform rating and a $72.00 price objective for the company. Mizuho set a $70.00 price objective on Cardinal Health and gave the company a hold rating in a research note on Tuesday, October 24th. Needham & Company LLC reiterated a hold rating on shares of Cardinal Health in a research note on Thursday, October 12th. Cowen upgraded Cardinal Health to a buy rating and set a $74.00 price objective for the company in a research note on Tuesday, October 10th. Finally, Evercore ISI assumed coverage on Cardinal Health in a research note on Thursday, January 4th. They set an in-line rating and a $67.00 price objective for the company. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have assigned a buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $73.58.

Cardinal Health (NYSE:CAH) opened at $71.91 on Wednesday. The stock has a market capitalization of $22,623.18, a price-to-earnings ratio of 13.65, a price-to-earnings-growth ratio of 1.65 and a beta of 0.85. Cardinal Health has a one year low of $54.66 and a one year high of $84.88. The company has a debt-to-equity ratio of 1.35, a quick ratio of 0.52 and a current ratio of 1.06.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Monday, November 6th. The company reported $1.09 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.00 by $0.09. The business had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $33.48 billion. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The firm’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.24 earnings per share. equities research analysts forecast that Cardinal Health will post 5.12 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Monday, January 15th. Stockholders of record on Tuesday, January 2nd were paid a $0.4624 dividend. This represents a $1.85 annualized dividend and a dividend yield of 2.57%. The ex-dividend date was Friday, December 29th. Cardinal Health’s dividend payout ratio is currently 53.78%.

Several hedge funds have recently bought and sold shares of CAH. Profund Advisors LLC raised its stake in shares of Cardinal Health by 20.7% in the second quarter. Profund Advisors LLC now owns 10,571 shares of the company’s stock worth $824,000 after purchasing an additional 1,812 shares during the last quarter. Artisan Partners Limited Partnership purchased a new position in shares of Cardinal Health in the second quarter worth $41,953,000. UBS Asset Management Americas Inc. raised its stake in shares of Cardinal Health by 6.1% in the second quarter. UBS Asset Management Americas Inc. now owns 1,409,051 shares of the company’s stock worth $109,793,000 after purchasing an additional 81,569 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of Cardinal Health by 1.9% in the second quarter. Vanguard Group Inc. now owns 23,642,277 shares of the company’s stock worth $1,842,205,000 after purchasing an additional 440,967 shares during the last quarter. Finally, TIAA FSB bought a new stake in shares of Cardinal Health in the second quarter worth $3,750,000. Hedge funds and other institutional investors own 88.36% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Cardinal Health’s (CAH) Hold Rating Reiterated at Robert W. Baird” was first posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://stocknewstimes.com/2018/01/21/cardinal-healths-cah-hold-rating-reiterated-at-robert-w-baird.html.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply